U.S. drug czar Sara Carter visited the Basilica of Our Lady of Guadalupe in Mexico City on February 26, 2026. Carter stated that with God’s blessing, the drug cartels and the poisons they spread will be overcome. The visit followed the recent capture and death of cartel leader Nemesio Oseguera Cervantes, alias “El Mencho,” aided by U.S. intelligence. Carter affirmed that faith is a cornerstone of her life and the U.S. National Drug Control strategy, guiding efforts against addiction.
5 days ago
Sara Carter, U.S. Director of the Office of National Drug Control Policy, visited the Basilica of Our Lady of Guadalupe in Mexico City on February 26, 2026.1 2
She was accompanied by Father Martín Muñoz López, vicar general of the Archdiocese of Mexico City and canon of the basilica.1 2
Carter prayed before the image on St. Juan Diego's tilma.1 2
Carter described faith as a "cornerstone" in the fight against drug addiction, guiding prevention, healing, and recovery.1 2
She affirmed that faith underpins both her personal life and the U.S. National Drug Control strategy.1 2
Carter prayed for people in the U.S. and Mexico under Our Lady's protection, seeking God's help to overcome "the plague of the cartels and the poisons they inflict on us and our children."1 2
The visit followed a February 22 operation in Jalisco state, where Nemesio Oseguera Cervantes, alias "El Mencho" and leader of the Jalisco New Generation Cartel, was captured and later died.1 2
Mexican Secretary of Security Omar García Harfuch credited U.S. authorities for providing key information enabling the operation.1 2
On February 25, Carter met Mexico's security cabinet alongside U.S. Ambassador Ronald Johnson.1 2
Participants included Mexican officials such as Secretary of National Defense Ricardo Trevilla, Secretary of the Navy Raymundo Morales, García Harfuch, Secretary of the Interior Rosa Icela Rodríguez, and Attorney General Ernestina Godoy.1 2
Johnson highlighted joint efforts to combat fentanyl and dismantle drug networks.1 2
Carter also met Foreign Minister Juan Ramón de la Fuente and Undersecretary Roberto Velasco Álvarez on anti-trafficking cooperation.1 2
Does Catholic faith shape U.S. drug‑control policy?
The Catholic Church consistently teaches that drug use and trafficking gravely harm human dignity, health, and society, viewing them as a "scourge" that demands comprehensive action including prevention, enforcement against traffickers, and rehabilitation. Popes from Paul VI to Francis have condemned the production, sale, and consumption of illicit drugs, calling traffickers "murderers" and "traffickers of death" driven by profit and power. Legalization is explicitly rejected as a solution, with Pope Francis stating it is a "fantasy" that increases consumption rather than reducing addiction. Instead, the Church emphasizes education in families and schools to foster moral values and human dignity, alongside compassionate treatment for addicts, including psychosocial support, employment opportunities, and reintegration.
This moral framework roots drug policy in the defense of life and the common good, linking addiction to broader societal breakdowns like family disintegration and materialism. Prevention must address root causes, such as existential voids and consumerist culture, while justice requires punishing major criminals without compromising efforts against petty users who are often victims themselves.
Catholic leaders have directly addressed U.S. policymakers, influencing discourse on drug control. In 1976, Pope Paul VI welcomed a U.S. Congressional Delegation on Drug Abuse, praising their efforts and urging severe legal measures against traffickers, public mobilization, and international coordination, while stressing prevention, education, and rehabilitation as essential to preserving human dignity. More recently, the U.S. Conference of Catholic Bishops (USCCB) has advocated for policies balancing punishment with restoration, echoing Pope Francis's call for rehabilitation over mere incarceration.
The USCCB supports bipartisan legislation like the Sentencing Reform and Corrections Act of 2015 (S. 2123) and Sentencing Reform Act of 2015 (H.R. 3713), which reduce federal mandatory minimums for certain drug offenses, make sentencing reforms retroactive (e.g., Fair Sentencing Act parity for crack vs. powder cocaine), expand judicial discretion via "safety valve" exceptions, and allow time credits for rehabilitative programs. They also back the Second Chance Reauthorization Act (S. 1513, H.R. 3406) for reentry programs focusing on education, job placement, and substance abuse treatment, often administered by faith-based groups. In 2023 legislative priorities, the USCCB listed drug abuse among threats to families, urging policies promoting family life, education, and health care to combat it.
Catholic advocacy shapes U.S. drug-control policy by providing a moral lens that prioritizes human dignity, restorative justice, and holistic responses over punitive-only approaches. Popes' addresses to U.S. leaders and USCCB lobbying have contributed to reforms emphasizing rehabilitation, as seen in support for reduced sentences for non-violent drug offenses and reentry initiatives—aligning with Church teachings on reintegration. For instance, the USCCB's endorsement of sentencing flexibility reflects papal calls for true justice that reforms offenders rather than abandoning them.
Historically, John Paul II highlighted family support and moral education as key to eradicating drugs, urging state backing for families as primary moral teachers—a principle echoed in USCCB priorities. The Church cooperates with government via Catholic institutions offering treatment and prevention, fostering policies like crop substitution for poor farmers tempted by drug production.
However, Catholic influence is advisory and collaborative, not determinative. U.S. policy emerges from legislative, executive, and societal inputs; Church positions compete with secular views favoring legalization or decriminalization, which contradict Catholic teaching. No sources indicate direct causation of specific laws, but consistent advocacy demonstrates shaping through ethical persuasion, public opinion mobilization, and partnerships.
Sources unanimously oppose drug liberalization and prioritize trafficker prosecution, addict rehabilitation, and prevention—recent statements (e.g., Francis in 2024) reinforcing earlier ones (e.g., John Paul II in 1987). Controversy arises in sentencing: while advocating mercy for minor offenders, the Church insists on strong action against networks, cautioning against reforms that undermine deterrence. USCCB support for reduced mandatory minimums applies to federal drug cases but aligns with broader restorative justice, not decriminalization.
In summary, Catholic faith shapes U.S. drug-control policy through authoritative moral teachings, direct papal addresses to policymakers, and USCCB advocacy for balanced reforms emphasizing prevention, enforcement against traffickers, and rehabilitation. This influence promotes policies upholding human dignity amid a complex policy landscape, though it operates via persuasion rather than control.